期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

Vogt-小柳原田综合征发病机制研究进展 被引量：7

Recent advances on pathogenesis of Vogt-Koyanagi-Harada syndrome
下载PDF
导出
摘要 Vogt-小柳原田综合征发病机制尚不完全清楚,目前的研究多倾向于认为该病为自身免疫性疾病,且与遗传因素有关。Fas/FasL表达异常、自身应答性T细胞的免疫调节异常,参与了Vogt-小柳原田综合征的发病过程。本文就近年来有关Vogt-小柳原田综合征发病机制的研究作一综述。 　Pathogenesis of Vogt-Koyanagi-Harada syndrome is unclear.At present,studies on this syndrome display that it is an autoimmune disease,concerned with genetic factor.Disordered expression of Fas/FasL and abnormal immunoregulation of autoresponsive T cell are involved in the development of Vogt-Koyanagi-Harada syndrome.This article reviews the pathogenesis of Vogt-Koyanagi-Harada syndrome studied in recent years.
作者 刘聪慧 郑燕林
机构地区 成都中医药大学
出处 《眼科新进展》 CAS 2007年第11期872-873,共2页 Recent Advances in Ophthalmology
关键词 VOGT-小柳原田综合征 发病机制 FAS/FASL Vogt-Koyanagi-Harada syndrome pathogenesis Fas/FasL
分类号 R773 [医药卫生—眼科]
  • 相关文献

参考文献11

  • 1陈慰峰.医学免疫学[M].北京：人民卫生出版社,2001..
  • 2Damico FM,Cunha-Ne E,Goldberg AC,Iwai LK,Marin ML,Hammer J,et al.T-cell recognition and cytokine profile induced by melanocyte epitopes in patients with HLA-DRB1·0405-positive and -negative Vogt-Koyanagi-Harada uveitis[J].Invest Ophthalmol Vis Sci 2005;46(7):2465-2471.
  • 3Miyazawa I,Abe T,Narikawa K,Feng J,Misu T,Nakashima I,et al.Chemokine profile in the cerebrospinal fluid and serum of Vogt-Koyanagi-Harada disease[J].J Neuroimmunol 2005;158(1-2):240-244.
  • 4Li B,Yang P,Zhou H,Huang X,Jin H,Chu L,et al.Upregulation of T-beta expression in peripheral blood mononuclear cells during Vogt-Koyanagi-Harada disease[J].Br J Ophthalmol 2005;89 (11):1410-1412.
  • 5Ohta K,Yoshimura N.Bcl-2 expression by CD4+ T lymphocytes in Vogt-Koyanagi-Harada disease[J].Ocul Immunol Inflamm 2002;10 (2):93-103.
  • 6Yang P,Chen L,Zhou H,Zhong H,Wang H,Huang X,et al.Resistance of lymphocytes to Fas-mediated apoptosis in Behet's disease and Vogt-Koyangi-Harada syndrome[J].Ocul Immunol Inflamm 2002;10 (1):47-52.
  • 7陈玲,杨培增,周红颜,黄祥坤,钟晖,谢楚芳.伏格特-小柳-原田综合征患者外周血淋巴细胞Fas和FasL mRNA的表达[J].中华眼科杂志,2004,40(8):507-509. 被引量：10
  • 8Ohkura T,Taniguchi S,Yamada K,Nishio N,Okamura T,Yoshida A,et al.Detection of the novel autoantibody (anti-UACA antibody) in patients with Graves' disease[J].Biochem Biophys Res Commun 2004;321 (2):432-440.
  • 9Otani S,Sakurai T,Yamamoto K,Fujita T,Matsuzaki Y,Goto Y,et al.Frequent immune response to a melanocyte-specific protein KU-MEL-1 in patients with Vogt-Koyanagi-Harada disease[J].Br J Ophthalmol 2006;90(6):773-777.
  • 10张美芬,邱长春,胡天圣.Vogt-Koyanagi-Harada综合征与HLA-DRB基因的相关性[J].中国医学科学院学报,2000,22(1):36-40. 被引量：9

二级参考文献17

  • 1Otsuki T, Sakaguchi H, Tookuni A, et al. Soluble Fas mRNA is dominantly expressed in cases with silicosis. Immunology, 1998,94:258-262.
  • 2Krammer PH, Dhein J, Walczak H, et al. The role of Apo-1 mediated apoptosis in the immune system. Immunol Rev, 1994,142:175-191.
  • 3Ferguson TA, Griffith TS. A vision of cell death: insight into immune privilege. Immunol Rev, 1997,156:167-184.
  • 4Yang P, Chen L, Zhou H, et al. Resistance of lymphocytes to Fasmediated apoptosiss in Behcet′s disease and Vogt-Koyangi-Harada syndrome. Ocul Immunol Inflamm, 2002,10:47-52.
  • 5Yang P, Ji L, Zhou H, et al. Disturbed expression of Fas/FasL on CD4 + and CD8 + T cells in Behcet′s disease, Vogt-KoyanagiHarada syndrome, and idiopathic anterior uveitis. Ocul Immunel Inflamm, 2001, 9:185-191.
  • 6Schneider P, Holler N, Bodmer JL, et al. Conversion of membranebound Fas (CD95) ligand to toxicity. J Exp Med, 1998, 187:1205-1213.
  • 7Mountz JD, Zhang HG, Hsu HC, et al. Apoptosis and cell death in the endocrine system. Recent Prog Horm Res, 1999, 54:235-268.
  • 8Hashimoto H, Tanaka M, Suda T, et al. Soluble Fas ligand in the joints of patients with rheumatoid arthritis and osteoarthritis. Arthritis Rheum, 1998,41:657-662.
  • 9Nozawa K, Kayagaki N, Tokano Y, et al. Soluble Fas (Apo-l, CD95 ) and soluble Fas ligand in rheumatic diseases. Arthritis Rheum, 1997,40:1126-1129.
  • 10Read RW, Holland GN, Rao NA, et al. Revised diagnostic criteria for Vogt-Koyanagi-Harada disease: report of an international committee on nomenclature. Am J Ophthalmol, 2001, 131: 647-652.

共引文献70

同被引文献38

引证文献7

二级引证文献12

眼科新进展
2007年 第11期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部